NEW YORK, Feb. 18, 2016 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Tower Semiconductor Ltd. securities (NASDAQ:TSEM) from April 30, 2012 through January 13, 2016, all dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Tower Semiconductor investors under the federal securities laws.
To join the Tower Semiconductor class action, go to the firm’s website at http://www.rosenlegal.com/cases-816.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll free at 866-767-3653 or email [email protected] or [email protected] for more information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE
According to the lawsuit, throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) the value of net tangible assets of the acquisition of a fabrication facility from Micron Technology Inc. was artificially inflated; (2) the value of net tangible assets of the acquisition of 51% of TowerJazz Panasonic Semiconductor Co., Ltd. from Panasonic Corporation was artificially inflated; (3) Tower Semiconductor’s Series F Debentures were incorrectly accounted for to understate debt; and (4) as a result, Defendants’ statements about Tower Semiconductor’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. The lawsuit alleges that when the truth of these allegations entered the market through a research report issued by Spruce Point Capital Management, the value to Tower securities dropped, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 22, 2016. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-816.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



